Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 13, 2025

October 13, 2025

AAFA Bill to Require Allergen Labeling in California Restaurants Becomes Law

GlobeNewswire

October 13, 2025

Polyols Market worth $21.59 billion by 2030, at a CAGR of 5.1%, says MarketsandMarkets™

GlobeNewswire

October 13, 2025

ImpactLife donor receives induction into National Blood Donation Hall of Fame

GlobeNewswire

October 13, 2025

Geron Corporation Announces Executive Leadership Transitions and Appointments

GlobeNewswire

October 13, 2025

Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

GlobeNewswire

October 13, 2025

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

October 13, 2025

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 13, 2025

Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings

GlobeNewswire

October 13, 2025

BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 13, 2025

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 13, 2025

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants

GlobeNewswire

October 13, 2025

Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)

GlobeNewswire

October 13, 2025

Neutrolis Announces Late-Breaking Oral Presentation of Clinical Results at American College of Rheumatology Convergence 2025

GlobeNewswire

October 13, 2025

Epista Launches Major Clinical Data Remediation Program with Global Pharma Leader

GlobeNewswire

October 13, 2025

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

GlobeNewswire

October 13, 2025

Pancreatic Endocrine Tumor Market Set to Witness Significant Growth During the Forecast Period (2025–2034) Owing to the Expected Launch of Therapies | DelveInsight

GlobeNewswire

October 13, 2025

Remix Therapeutics to Present Phase 1 Data of REM-422 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Conference in Late-Breaking Oral Presentation

GlobeNewswire

October 13, 2025

Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium

GlobeNewswire

October 13, 2025

Press release: Transparency Notification from Shareholder

GlobeNewswire

October 13, 2025

Merus kondigt de selectie aan van het abstract: Petosemtamab in Metastatic Colorectal Cancer (petosemtamab in gemetastaseerde colorectale kanker) voor mondelinge presentatie in de plenaire sessie op de AACR-NCI-EORTC International Conference on…

GlobeNewswire